Viral Persistence: HIV's Strategies of Immune System Evasion
- 1 February 2002
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 53 (1) , 499-518
- https://doi.org/10.1146/annurev.med.53.082901.104053
Abstract
▪ Abstract In contrast to most animal viruses, infection with the human and simian immunodeficiency viruses results in prolonged, continuous viral replication in the infected host. Remarkably, viral persistence is not thwarted by the presence of apparently vigorous, virus-specific immune responses. Several factors are thought to contribute to persistent viral replication, most notably the destruction of virus-specific T helper cells, the emergence of antigenic escape variants, and the expression of an envelope complex that structurally minimizes antibody access to conserved epitopes. Not as well understood, though potentially important, is the ability of at least one viral encoded protein (Nef) to prevent presentation of viral antigens in the context of major histocompatibility complex. The future success of antiviral therapies and vaccination strategies may depend largely on understanding how and to what degree each of these factors (and presumably others) contributes to immune evasion.Keywords
This publication has 156 references indexed in Scilit:
- A Single Residue Exchange Within a Viral CTL Epitope Alters Proteasome-Mediated Degradation Resulting in Lack of Antigen PresentationImmunity, 1996
- Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and RecipientsScience, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Hypothetical Assignment of Intrachain Disulfide Bonds for HIV-2 and SIV Envelope GlycoproteinsAIDS Research and Human Retroviruses, 1991
- Importance of the nef gene for maintenance of high virus loads and for development of AIDSCell, 1991
- Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope geneCell, 1988
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigensCell, 1985
- Antigenic variation in visna virusCell, 1979